The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine
Open accessAbstract
Artificial intelligence (AI) encompasses a broad spectrum of techniques that have been utilized by pharmaceutical companies for decades, including machine learning, deep learning, and other advanced computational methods. These innovations have unlocked unprecedented opportunities for the acceleration of drug discovery and delivery, the optimization of treatment regimens, and the improvement of patient outcomes. AI is swiftly transforming the pharmaceutical industry, revolutionizing everything from drug development and discovery to personalized medicine, including target identification and validation, selection of excipients, prediction of the synthetic route, supply chain optimization, monitoring during continuous manufacturing processes, or predictive maintenance, among others. While the integration of AI promises to enhance efficiency, reduce costs, and improve both medicines and patient health, it also raises important questions from a regulatory point of view. In this review article, we will present a comprehensive overview of AI’s applications in the pharmaceutical industry, covering areas such as drug discovery, target optimization, personalized medicine, drug safety, and more. By analyzing current research trends and case studies, we aim to shed light on AI’s transformative impact on the pharmaceutical industry and its broader implications for healthcare.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Landscape of Pharmacogenomic Interactions in Cancer
Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.017 · Cited by 2,090
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573 · cited 1×
“By using an in-house AI algorithm after screening billions of molecules and identifying a promising candidate that moved on into preclinical trials [50,122].”
MethodArtificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Vora, L. K., Gholap, A. D., Jetha, K., Thakur, R. R. S., Solanki, H. K., & Chavda, V. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071916 · Cited by 1,061
The imperative for regulatory oversight of large language models (or generative AI) in healthcare
Meskó, B., & Topol, E. J. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00873-0 · Cited by 1,047
Liu, D., Schilling, B., Liu, D., Sucker, A., Livingstone, E., Jerby-Arnon, L., Zimmer, L., Gutzmer, R., Satzger, I., Loquai, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0654-5 · Cited by 1,039
Molecular Transformer: A Model for Uncertainty-Calibrated Chemical Reaction Prediction
Schwaller, P., Laino, T., Gaudin, T., Bolgar, P., Hunter, C. A., Bekas, C., & Lee, A. A. (2019) · ACS Central Science · doi:10.1021/acscentsci.9b00576 · Cited by 928
Rethinking drug design in the artificial intelligence era
Schneider, P., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0050-3 · Cited by 894
Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production
Lee, S. L., O’Connor, T. F., Yang, X., Cruz, C. N., Chatterjee, S., Madurawe, R. D., Moore, C. M. V., Yu, L. X., & Woodcock, J. (2015) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-015-9215-8 · Cited by 877
Machine Learning in Drug Discovery: A Review
Dara, S., Dhamercherla, S., Jadav, S. S., Babu, C. M., & Ahsan, M. J. (2022) · Artificial Intelligence Review · doi:10.1007/s10462-021-10058-4 · Cited by 792
Artificial Intelligence in Cancer Research and Precision Medicine
Bhinder, B., Gilvary, C., Madhukar, N. S., & Elemento, O. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0090 · Cited by 781
The role of AI in drug discovery: challenges, opportunities, and strategies
Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023) · Pharmaceuticals · doi:10.3390/ph16060891 · Cited by 690
Digital pathology and artificial intelligence in translational medicine and clinical practice
Baxi, V., Edwards, R., Montalto, M., & Saha, S. (2022) · Modern Pathology · doi:10.1038/s41379-021-00919-2 · Cited by 592
Predicting drug response and synergy using a deep learning model of human cancer cells
Kuenzi, B. M., Park, J., Fong, S. H., Sanchez, K. S., Lee, J., Kreisberg, J. F., Ma, J., & Ideker, T. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.09.014 · Cited by 544
Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine
Adir, O., Poley, M., Chen, G., Froim, S., Krinsky, N., Shklover, J., Shainsky‐Roitman, J., Lammers, T., & Schroeder, A. (2020) · Advanced Materials · doi:10.1002/adma.201901989 · Cited by 496
A review on machine learning approaches and trends in drug discovery
Carracedo-Reboredo, P., Liñares-Blanco, J., Rodríguez-Fernández, N., Cedrón, F., Novoa, F. J., Carballal, A., Maojo, V., Pazos, A., & Fernandez-Lozano, C. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.011 · Cited by 472
O'Sullivan, S., Nevejans, N., Allen, C., Blyth, A., Leonard, S., Pagallo, U., Holzinger, K., Holzinger, A., Sajid, M. I., & Ashrafian, H. (2019) · The International Journal of Medical Robotics and Computer Assisted Surgery · doi:10.1002/rcs.1968 · Cited by 437 · cited 1×
“Finally, regulatory and ethical considerations will become by far more important as AI technologies become more integrated into pharmaceutical practices to ensure the transparency, fairness, and accountability of AI systems as well as maintain trust and compliance within the industry [178–186].”
BackgroundA survey on AI-driven digital twins in Industry 4.0: smart manufacturing and advanced robotics
Huang, Z., Shen, Y., Li, J., Fey, M., & Brecher, C. (2021) · Sensors · doi:10.3390/s21196340 · Cited by 418 · cited 1×
“AI-driven digital twins will simulate and optimize manufacturing processes in real-time, while predictive maintenance algorithms will prevent equipment failures and minimize downtime, facilitating more agile and responsive manufacturing operations [171–173].”
Deep learning in drug discovery: an integrative review and future challenges
Askr, H., Elgeldawi, E., Aboul Ella, H., Elshaier, Y. A. M. M., Gomaa, M. M., & Hassanien, A. E. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-022-10306-1 · Cited by 390
Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalhães, P., Schmidt, S., & Vale, N. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030332 · Cited by 390
Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development
Sarkar, C., Das, B., Rawat, V. S., Wahlang, J. B., Nongpiur, A., Tiewsoh, I., Lyngdoh, N. M., Das, D., Bidarolli, M., & Sony, H. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032026 · Cited by 347
Utilizing graph machine learning within drug discovery and development
Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R., Roberts, C., Tang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab159 · Cited by 313
Personalised 3D Printed Medicines: Which Techniques and Polymers Are More Successful?
Konta, A., García-Piña, M., & Serrano, D. (2017) · Bioengineering · doi:10.3390/bioengineering4040079 · Cited by 301
Self-citationFernández-García, R., Lalatsa, A., Statts, L., Bolás-Fernández, F., Ballesteros, M. P., & Serrano, D. R. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118817 · Cited by 289
Self-citationDhakal, A., McKay, C., Tanner, J. J., & Cheng, J. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab476 · Cited by 256
Predicting Retrosynthetic Reactions Using Self-Corrected Transformer Neural Networks
Zheng, S., Rao, J., Zhang, Z., Xu, J., & Yang, Y. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00949 · Cited by 249
Machine learning applications in drug development
Réda, C., Kaufmann, E., & Delahaye-Duriez, A. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.12.006 · Cited by 228
CURATE.AI: Optimizing Personalized Medicine with Artificial Intelligence
Blasiak, A., Khong, J., & Kee, T. (2020) · SLAS Technology · doi:10.1177/2472630319890316 · Cited by 222
Artificial intelligence in drug discovery: applications and techniques
Deng, J., Yang, Z., Ojima, I., Samaras, D., & Wang, F. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab430 · Cited by 220
Carpenter, K. A., & Huang, X. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180607124038 · Cited by 197
Unleashing the power of generative AI in drug discovery
Gangwal, A., & Lavecchia, A. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103992 · Cited by 195
3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals
Serrano, D. R., Kara, A., Yuste, I., Luciano, F. C., Ongoren, B., Anaya, B. J., Molina, G., Diez, L., Ramirez, B. I., Ramirez, I. O., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020313 · Cited by 192
Self-citationDas, K. P., & J, C. (2023) · Frontiers in Medical Technology · doi:10.3389/fmedt.2022.1067144 · Cited by 191
Niazi, S. K. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s424991 · Cited by 184
Johannet, P., Coudray, N., Donnelly, D. M., Jour, G., Illa-Bochaca, I., Xia, Y., Johnson, D. B., Wheless, L., Patrinely, J. R., Nomikou, S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2415 · Cited by 180
Advances in artificial intelligence for drug delivery and development: A comprehensive review
Gholap, A. D., Uddin, M. J., Faiyazuddin, M., Omri, A., Gowri, S., & Khalid, M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108702 · Cited by 179
Identification of non-small cell lung cancer sensitive to systemic cancer therapies using radiomics
Dercle, L., Fronheiser, M., Lu, L., Du, S., Hayes, W., Leung, D. K., Roy, A., Wilkerson, J., Guo, P., Fojo, A. T., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2942 · Cited by 177 · cited 1×
“…of six machine learning algorithms to predict patient sensitivity (defined as progression-free survival beyond the population median) to chemotherapy, targeted therapy, and immunotherapy by analyzing quantitative features from longitudinal CT scans of non-small cell lung cancer patients [60].”
BackgroundRevolutionizing clinical trials: the role of AI in accelerating medical breakthroughs
Chopra, H., Annu, Shin, D. K., Munjal, K., Priyanka, Dhama, K., & Emran, T. B. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000705 · Cited by 177
Harnessing artificial intelligence for the next generation of 3D printed medicines
Elbadawi, M., McCoubrey, L. E., Gavins, F. K. H., Ong, J. J., Goyanes, A., Gaisford, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.015 · Cited by 172
Wearable movement-tracking data identify Parkinson’s disease years before clinical diagnosis
Schalkamp, A.-K., Peall, K. J., Harrison, N. A., & Sandor, C. (2023) · Nature Medicine · doi:10.1038/s41591-023-02440-2 · Cited by 168
AI-based language models powering drug discovery and development
Liu, Z., Roberts, R. A., Lal-Nag, M., Chen, X., Huang, R., & Tong, W. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.06.009 · Cited by 167
Sharma, A., Virmani, T., Pathak, V., Sharma, A., Pathak, K., Kumar, G., & Pathak, D. (2022) · BioMed Research International · doi:10.1155/2022/7205241 · Cited by 165
Universal Chemical Synthesis and Discovery with ‘The Chemputer’
Gromski, P. S., Granda, J. M., & Cronin, L. (2019) · Trends in Chemistry · doi:10.1016/j.trechm.2019.07.004 · Cited by 161
Artificial intelligence: Machine learning approach for screening large database and drug discovery
Parvatikar, P., Patil, S., Khaparkhuntikar, K., Patil, S., Singh, P. K., Sahana, R., Kulkarni, R. V., & Raghu, A. V. (2023) · Antiviral Research · doi:10.1016/j.antiviral.2023.105740 · Cited by 147
The Role of AI in Drug Discovery
Abbas, M. K. G., Rassam, A., Karamshahi, F., Abunora, R., & Abouseada, M. (2024) · ChemBioChem · doi:10.1002/cbic.202300816 · Cited by 140
An AI boost for clinical trials
Woo, M. (2019) · Nature · doi:10.1038/d41586-019-02871-3 · Cited by 134
How AI is being used to accelerate clinical trials
Hutson, M. (2024) · Nature · doi:10.1038/d41586-024-00753-x · Cited by 131
Artificial intelligence-powered microfluidics for nanomedicine and materials synthesis
Liu, L., Bi, M., Wang, Y., Liu, J., Jiang, X., Xu, Z., & Zhang, X. (2021) · Nanoscale · doi:10.1039/d1nr06195j · Cited by 130
Artificial Intelligence for Retrosynthesis Prediction
Jiang, Y., Yu, Y., Kong, M. C., Mei, Y., Yuan, L., Huang, Z., Kuang, K., Wang, Z., Yao, H., Zou, J., et al. (2022) · Engineering · doi:10.1016/j.eng.2022.04.021 · Cited by 121
Oral Particle Uptake and Organ Targeting Drives the Activity of Amphotericin B Nanoparticles
Serrano, D. R., Lalatsa, A., Dea‐Ayuela, M. A., Bilbao-Ramos, P. E., Garrett, N., Moger, J., Guarro, J., Capilla, J., Ballesteros, M. P., Schätzlein, A. G., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500527x · Cited by 117
Self-citationAccelerated chemical science with AI
Back, S., Aspuru‐Guzik, A., Ceriotti, M., Gryn’ova, G., Grzybowski, B. A., Gu, G. H., Hein, J. E., Hippalgaonkar, K., Hormázabal, R., Jung, Y., et al. (2023) · Digital Discovery · doi:10.1039/d3dd00213f · Cited by 110
Sheu, Y.-H., Magdamo, C., Miller, M. R., Das, S., Blacker, D., & Smoller, J. W. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00817-8 · Cited by 109
Alhijjaj, M., Nasereddin, J., Belton, P., & Qi, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120633 · Cited by 106
Artificial intelligence for compound pharmacokinetics prediction
Obrezanova, O. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102546 · Cited by 104
AI in drug development: a multidisciplinary perspective
Gallego, V., Naveiro, R., Roca, C., Insua, D. R., & Campillo, N. E. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10266-8 · Cited by 103
“Artificial Intelligence” for Pharmacovigilance: Ready for Prime Time?
Ball, R., & Pan, G. J. D. (2022) · Drug Safety · doi:10.1007/s40264-022-01157-4 · Cited by 96
Derraz, B., Breda, G., Kaempf, C., Baenke, F., Cotte, F., Reiche, K., Köhl, U., Kather, J. N., Eskenazy, D., & Gilbert, S. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00517-w · Cited by 94
Ayyoubi, S., Cerda, J. R., Fernández-García, R., Knief, P., Lalatsa, A., Healy, A. M., & Serrano, D. R. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120336 · Cited by 93
Self-citationObeid, S., Madžarević, M., Krkobabić, M., & Ibric, S. R. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120507 · Cited by 92
Liu, Q., Huang, R., Hsieh, J., Zhu, H., Tiwari, M., Liu, G., Jean, D., ElZarrad, M. K., Fakhouri, T. H. I., Berman, S., et al. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2668 · Cited by 92
Calaprice, D., Galil, K., Salloum, W., Zariv, A., & Jimenez, B. (2020) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-019-00030-4 · Cited by 90
Danishuddin, M., Kumar, V., Faheem, M., & Lee, K. W. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.09.013 · Cited by 86
Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations
Serrano, D. R., Hernández, L., Fleire, L., González-Alvarez, I., Montoya, A., Ballesteros, M. P., Dea‐Ayuela, M. A., Miró, G., Bolás-Fernández, F., & Torrado, J. J. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.038 · Cited by 84
Self-citationCerda, J. R., Arifi, T., Ayyoubi, S., Knief, P., Ballesteros, M. P., Keeble, W., Barbu, E., Healy, A. M., Lalatsa, A., & Serrano, D. R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040345 · Cited by 80
Self-citationApplications of Machine Learning in Solid Oral Dosage Form Development
Lou, H., Lian, B., & Hageman, M. J. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.04.013 · Cited by 77
Increasing acceptance of AI ‐generated digital twins through clinical trial applications
Vidovszky, A. A., Fisher, C. K., Loukianov, A. D., Smith, A. M., Tramel, E. W., Walsh, J. R., & Ross, J. L. (2024) · Clinical and Translational Science · doi:10.1111/cts.13897 · Cited by 77
Mapping the regulatory landscape of AI in healthcare in Africa
Townsend, B. A., Sihlahla, I., Naidoo, M., Naidoo, S., Donnelly, D.-L., & Thaldar, D. W. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1214422 · Cited by 76
Bess, A., Berglind, F., Mukhopadhyay, S., Bryliński, M., Griggs, N. W., Cho, T., Galliano, C., & Wasan, K. M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.022 · Cited by 70
An, G. C., & Cockrell, C. (2022) · Frontiers in Systems Biology · doi:10.3389/fsysb.2022.928387 · Cited by 68
Fernández-García, R., Prada, M., Bolás-Fernández, F., Ballesteros, M. P., & Serrano, D. R. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02847-3 · Cited by 66
Self-citationPetrick, N., Chen, W., Delfino, J. G., Gallas, B. D., Kang, Y., Krainak, D. M., Sahiner, B., & Samala, R. K. (2023) · Journal of medical imaging · doi:10.1117/1.jmi.10.5.051804 · Cited by 66
Revolutionizing Sleep Health: The Emergence and Impact of Personalized Sleep Medicine
Garbarino, S., & Bragazzi, N. L. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14060598 · Cited by 66
AI-Powered Microfluidics: Shaping the Future of Phenotypic Drug Discovery
Liu, J., Du, H., Huang, L., Xie, W., Liu, K., Zhang, X., Chen, S., Zhang, Y., Li, D., & Pan, H. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c07665 · Cited by 64
Stafford, K. A., Anderson, B., Sorenson, J. M., & van den Bedem, H. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01250 · Cited by 63
Machine learning for target discovery in drug development
Rodrigues, T., & Bernardes, G. J. L. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.10.003 · Cited by 62
Walsh, D. P., Serrano, D. R., Worku, Z. A., Madi, A. M., O'Connell, P., Twamley, B., & Healy, A. M. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.029 · Cited by 61
Self-citationChang, W., Liu, C., Feng, Y., Liao, C., Wang, J., Chen, Z., Lee, H., & Shih, J. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03341-y · Cited by 61
DrugFlow: An AI-Driven One-Stop Platform for Innovative Drug Discovery
Shen, C., Song, J., Hsieh, C., Cao, D., Kang, Y., Ye, W., Wu, Z., Wang, J., Zhang, O., Zhang, X., et al. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00621 · Cited by 61
Artificial Intelligence for Precision Oncology
Bhalla, S., & Laganà, A. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-91836-1_14 · Cited by 60
Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis
Smith, L. D., Serrano, D. R., Mauger, M., Bolás-Fernández, F., Dea‐Ayuela, M. A., & Lalatsa, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00097 · Cited by 59
Self-citationDeep learning for continuous manufacturing of pharmaceutical solid dosage form
Roggo, Y., Jelsch, M., Heger, P., Enßlin, S., & Krumme, M. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.06.002 · Cited by 58
An integrated self-optimizing programmable chemical synthesis and reaction engine
Leonov, A. I., Hammer, A. J. S., Lach, S., Mehr, S. H. M., Caramelli, D., Angelone, D., Khan, A., O’Sullivan, S., Craven, M., Wilbraham, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45444-3 · Cited by 58
Liu, Q., Zhu, H., Liu, C., Jean, D., Huang, S. M., ElZarrad, M. K., Blumenthal, G. M., & Wang, Y. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1771 · Cited by 56
Fernández-García, R., Muñoz-García, J. C., Wallace, M., Fábián, L., González‐Burgos, E., Gómez-Serranillos, M. P., Raposo, R., Bolás-Fernández, F., Ballesteros, M. P., Healy, A. M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.019 · Cited by 56
Self-citationIyer, J. S., Juyal, D., Le, Q., Shanis, Z., Pokkalla, H., Pouryahya, M., Pedawi, A., Stanford-Moore, S. A., Biddle-Snead, C., Carrasco-Zevallos, O., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03172-7 · Cited by 54
Impact of Artificial Intelligence on Drug Development and Delivery
Aundhia, C. J., Parmar, G. R., Talele, C., Shah, N., & Talele, D. R. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266324522240725053634 · Cited by 54
The case for AI-driven cancer clinical trials – The efficacy arm in silico
Kolla, L., Gruber, F. K., Khalid, O. M., Hill, C., & Parikh, R. B. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188572 · Cited by 53
Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines
Kara, A., Vassiliadou, A., Öngoren, B., Keeble, W., Hing, R., Lalatsa, A., & Serrano, D. R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122134 · Cited by 53
Self-citationLeitner, J., Chiang, P.-H., Agnihotri, P., & Dey, S. (2024) · JMIR Cardio · doi:10.2196/51916 · Cited by 53
AI in imaging: the regulatory landscape
Hill, D. L. G. (2024) · British Journal of Radiology · doi:10.1093/bjr/tqae002 · Cited by 52 · cited 1×
“Finally, regulatory and ethical considerations will become by far more important as AI technologies become more integrated into pharmaceutical practices to ensure the transparency, fairness, and accountability of AI systems as well as maintain trust and compliance within the industry [178–186].”
Backgroundvan Kolfschooten, H. (2023) · Journal of Law and the Biosciences · doi:10.1093/jlb/lsad031 · Cited by 52
The recent advances in the approach of artificial intelligence (AI) towards drug discovery
Khan, M. K., Raza, M., Shahbaz, M., Hussain, I., Khan, M. F., Xie, Z., Shah, S. S. A., Tareen, A. K., Bashir, Z., & Khan, K. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1408740 · Cited by 51
Application of Artificial Intelligence in Drug Discovery
Chopra, H., Baig, A. A., Gautam, R. K., & Kamal, M. A. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220608141049 · Cited by 50
Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating
Serrano, D. R., Walsh, D. P., O'Connell, P., Mugheirbi, N. A., Worku, Z. A., Bolás-Fernández, F., Galiana, C., Dea‐Ayuela, M. A., & Healy, A. M. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.11.015 · Cited by 48
Self-citationArtificial intelligence-driven prediction of multiple drug interactions
Chen, S., Li, T., Yang, L., Zhai, F., Jiang, X., Xiang, R., & Ling, G. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac427 · Cited by 44
Momeni, M., Afkanpour, M., Rakhshani, S., Mehrabian, A., & Tabesh, H. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02485-4 · Cited by 44
AI's potential to accelerate drug discovery needs a reality check
(2023) · Nature · doi:10.1038/d41586-023-03172-6 · Cited by 42
AlphaKnot: server to analyze entanglement in structures predicted by AlphaFold methods
Niemyska, W., Rubach, P., Gren, B. A., Nguyen, M. L., Garstka, W., da Silva, F. B., Rawdon, E. J., & Sulkowska, J. I. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac388 · Cited by 42
Future of machine learning in paediatrics
Clarke, S. L. N., Parmesar, K., Saleem, M. A., & Ramanan, A. V. (2021) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-321023 · Cited by 40
Patel, S., Patel, M. M., Kulkarni, M., & Patel, M. S. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122839 · Cited by 40
Recent progress in machine learning approaches for predicting carcinogenicity in drug development
Le, N. Q. K., Tran, T.-X., Nguyen, P.-A., Ho, T.-T., & Nguyen, V. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2356162 · Cited by 38
Gonsard, A., Taam, R. A., Prévost, B., Roy, C., Hadchouel, A., Nathan, N., Taytard, J., Pirojoc, A., Delacourt, C., Wanin, S., et al. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04754-8 · Cited by 37
Matji, A., Donato, N., Gagol, A., Morales, E., Carvajal, L., Serrano, D. R., Worku, Z. A., Healy, A. M., & Torrado, J. J. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.011 · Cited by 36
Self-citationLam, B., Catt, M., Cassidy, S., Bacardit, J., Darke, P., Butterfield, S., Alshabrawy, O. S., Trenell, M. I., & Missier, P. (2021) · JMIR Diabetes · doi:10.2196/23364 · Cited by 34
AI enhances drug discovery and development
Bai, F., Li, S., & Li, H. (2023) · National Science Review · doi:10.1093/nsr/nwad303 · Cited by 32
The Oral Delivery of Amphotericin B
Torrado, J. J., Serrano, D. R., & Uchegbu, I. F. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.134 · Cited by 31
Self-citationXu, X., Mazloom, R., Goligerdian, A., Staley, J. M., Amini, M., Wyckoff, G. J., Riviere, J. E., & Jaberi‐Douraki, M. (2019) · Topics in companion animal medicine · doi:10.1016/j.tcam.2019.100366 · Cited by 29
Chakravarty, K., Antontsev, V. G., Khotimchenko, M., Gupta, N., Jagarapu, A., Bundey, Y., Hou, H., Maharao, N. V., & Varshney, J. (2021) · Molecules · doi:10.3390/molecules26071912 · Cited by 29
Open data and algorithms for open science in AI-driven molecular informatics
Brinkhaus, H. O., Rajan, K., Schaub, J., Zielesny, A., & Steinbeck, C. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102542 · Cited by 29
New aerosol formulation to control ciprofloxacin pulmonary concentration
Lamy, B., Tewes, F., Serrano, D. R., Lamarche, I., Gobin, P., Couet, W. R., Healy, A. M., & Marchand, S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.021 · Cited by 28
Self-citationPredictive maintenance in pharmaceutical manufacturing lines using deep transformers
Kavasidis, I., Lallas, E., Gerogiannis, V. C., et al. (2023) · Procedia Computer Science · doi:10.1016/j.procs.2023.03.073 · Cited by 28
Machine learning for antidepressant treatment selection in depression
Arnold, P. I. M., Janzing, J., & Hommersom, A. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104068 · Cited by 28
Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)
Brasil, S., Allocca, M., Magrinho, S. C. M., Santos, I., Raposo, M., Francisco, R., Pascoal, C., Martins, T., Videira, P. A., Pereira, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158725 · Cited by 27
Chatterjee, A., Pahari, N., Prinz, A., & Riegler, M. A. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02364-4 · Cited by 27
When can AI deliver the drug discovery hits?
Mullard, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/d41573-024-00036-0 · Cited by 27
Data‐Driven Intelligent Manipulation of Particles in Microfluidics
Fang, W., Xiong, T., Pak, O. S., & Zhu, L. (2022) · Advanced Science · doi:10.1002/advs.202205382 · Cited by 26
Stankoski, S., Jordan, M., Gjoreski, H., & Luštrek, M. (2021) · Sensors · doi:10.3390/s21051902 · Cited by 25
Next Decade’s AI-Based Drug Development Features Tight Integration of Data and Computation
Luo, Y., Peng, J., & Ma, J. (2022) · Health Data Science · doi:10.34133/2022/9816939 · Cited by 23
Patients should be informed when AI systems are used in clinical trials
Perni, S., Lehmann, L. S., & Bitterman, D. S. (2023) · Nature Medicine · doi:10.1038/s41591-023-02367-8 · Cited by 23
Revolutionizing pharmacokinetics: the dawn of AI-powered analysis
Ghayoor, A., & Kohan, H. G. (2024) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2024.12671 · Cited by 22
Connor, S., Li, T., Roberts, R. A., Thakkar, S., Liu, Z., & Tong, W. (2022) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2022.1034631 · Cited by 21
Kargarandehkordi, A., Slade, C. R., & Washington, P. Y. (2024) · JMIR Research Protocols · doi:10.2196/55615 · Cited by 21
Recent development of machine learning models for the prediction of drug-drug interactions
Hong, E., Jeon, J., & Kim, H. U. (2023) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-023-1377-3 · Cited by 20
Engineering 3D-Printed Advanced Healthcare Materials for Periprosthetic Joint Infections
Yuste, I., Luciano, F. C., Anaya, B. J., Sanz-Ruíz, P., Ribed, A., González‐Burgos, E., & Serrano, D. R. (2023) · Antibiotics · doi:10.3390/antibiotics12081229 · Cited by 20
Self-citationWeight Loss with an AI-Powered Digital Platform for Lifestyle Intervention
Khokhar, S., Holden, J., Toomer, C., & Parigi, A. D. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07209-1 · Cited by 20
Mshani, I. H., Jackson, F. M., Mwanga, R. Y., Kweyamba, P. A., Mwanga, E. P., Tambwe, M. M., Hofer, L. M., Siria, D. J., González‐Jiménez, M., Wynne, K., et al. (2024) · Malaria Journal · doi:10.1186/s12936-024-05011-z · Cited by 20
Yuan, H., Tong, X., Ren, Y., Li, Y., Wang, X., Chen, L., Chen, S., Jin, X., Wang, X., Targher, G., et al. (2024) · Liver International · doi:10.1111/liv.16025 · Cited by 20
Mobile applications on app stores for deprescribing: A scoping review
Okati, L., Lo, S. Y., Gnjidic, D., Li, S. J., & Thillainadesan, J. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16191 · Cited by 20
Siddiqui, G. A., Stebani, J. A., Wragg, D., Koutsourelakis, P., Casini, A., & Gagliardi, A. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202302375 · Cited by 16
Ongoren, B., Kara, A., Casettari, L., Tiboni, M., Lalatsa, A., Sanz-Perez, A., González-Burgos, E., Romero, A., Juberías, A., Torrado, J., et al. (2024) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2024.124536 · Cited by 15
Self-citationTransforming drug development with synthetic biology and AI
Hill, A. B., True, J. M., & Jones, C. H. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.01.008 · Cited by 14
The Introduction of AI Into Decentralized Clinical Trials
Goldberg, J. M., Amin, N. P., Vadaketh, K., & Bhatt, A. B. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101094 · Cited by 13
Barrett, J. S., Oskoui, S. E., Russell, S., & Borens, A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1115356 · Cited by 11
Alqarni, M. A., Namazi, N. I., Alshehri, S., Naguib, I. A., Alsubaiyel, A. M., Venkatesan, K., Elmokadem, E. M., Pishnamazi, M., & Abourehab, M. A. S. (2022) · Molecules · doi:10.3390/molecules27144357 · Cited by 10
A systematic review of generative adversarial networks (GANs) in plastic surgery
Zargaran, A., Sousi, S., Glynou, S. P., Mortada, H. H., Zargaran, D., & Mosahebi, A. (2024) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2024.04.007 · Cited by 10
Liu, X., & Read, S. J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1349576 · Cited by 9
Beis, G., Serafeim, A. P., & Papasotiriou, I. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.11.042 · Cited by 8
Roche, V., Robert, J.-P., & Salam, H. (2023) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2023.102638 · Cited by 8
Yoon, J. T., Lee, K. M., Oh, J.-H., Kim, H., & Jeong, J. W. (2024) · Diagnostics · doi:10.3390/diagnostics14161756 · Cited by 8
Transforming Cancer Care: The Impact of AI-driven Strategies
Mukherjee, D., Roy, D., & Thakur, S. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096323564240703102748 · Cited by 5
Views on artificial intelligence (AI) assisted clinical trials
Balsundaram, A. (2021) · Bioinformation · doi:10.6026/97320630017616 · Cited by 3
Towards Responsible AI in Patient Education: Ethical, Linguistic, and Regulatory Considerations
Samaan, J. S., Yeo, Y. H., Rajeev, N. D., Ng, W. H., Srinivasan, N., & Samakar, K. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06877-9 · Cited by 3
Harnessing the power of AI-based models to accelerate drug discovery against immune diseases
Moingeon, P. E. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2373915 · Cited by 3
Generative AI intervention clinical trials: a call for pre-registration – correspondence
Wu, H., Sun, Z., Guo, Q., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001690 · Cited by 2
Cited by
Allgayer, H., Mahapatra, S., Mishra, B., Swain, B., Saha, S., Khanra, S., Kumari, K., Panda, V. K., Malhotra, D., Patil, N. S., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02338-2 · Cited by 127
Samad, M. A., Ahmad, I., Zughaibi, T. A., Suhail, M., Zaidi, S. K., Al-Abbasi, F. A., & Tabrez, S. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100268 · Cited by 35
Abbas, S. R., Abbas, Z., Zahir, A., & Lee, S. W. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf329 · Cited by 30
The impact of AI on modern oncology from early detection to personalized cancer treatment
Li, J., Zhang, L., Yu, Z., Bao, Z., Li, D., & Wang, L. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01276-6 · Cited by 24
Osonuga, A., Olawade, D. B., Gore, M., Rotifa, O. B., Egbon, E., Chinwah, V., & Boussios, S. (2025) · Annals of Translational Medicine · doi:10.21037/atm-25-62 · Cited by 8
Metadata
- Authors
- Serrano, D. R., Luciano, F. C., Anaya, B. J., Ongoren, B., Kara, A., Molina, G., Ramirez, B. I., Sánchez-Guirales, S. A., Simon, J. A., Tomietto, G., Rapti, C., Ruiz, H. K., Rawat, S., Kumar, D., & Lalatsa, A.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2024-10-14
- Volume
- 16
- Issue
- 10
- Pages
- 1328
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W4403402994
- Cited by
- 488
- References
- 145
- FWCI
- 95.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.